Rasagiline Tablet
Product Images NDC 51407-009

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rasagiline (NDC 51407-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mock (51407-008-30TBD- Rasaglinie Tablets 0.5 mg)

This text provides information about Rasagiline tablets with a dosage of 0.5 mg. Pharmacist should dispense the Medication Guide to each patient. The tablets contain 0.78 mg of rasagiline mesylate. The package is child-resistant and should be stored at 20° to 25°C. Further details on the dosage can be found in the accompanying prescribing information.*

FDA Label Image

Mock (51407-009-30TBD- Rasaglinie Tablets 1 mg)

This is a prescription medication called Rasagiline, in tablet form. Each tablet contains 1 mg of rasagiline. The dosage instructions should be followed as per the accompanying prescribing information. The medication guide should be provided to each patient by the pharmacist. It is important to keep the medication out of reach of children. The package is child-resistant. It is advised to store the medication at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). This medication is manufactured by GSMS, Incorporated in Camarillo, California, USA.*

FDA Label Image

Chemical Structure (Structure01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.